Baltimore-Washington Financial Advisors’s Celgene Corp CELG Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-28,094	Closed	-$2.94M	–	79
2016 Q3	$2.94M	Sell	28,094 -1,665	-6%	-$180K	0.84%	54
2016 Q2	$2.94M	Buy	29,759 +1,665	+6%	+$172K	0.87%	53
2016 Q1	$2.81M	Buy	28,094 +4,691	+20%	+$483K	0.85%	55
2015 Q4	$2.8M	Buy	23,403 +1,837	+9%	+$213K	0.88%	55
2015 Q3	$2.33M	Sell	21,566 -37	-0.2%	-$4.59K	0.74%	62
2015 Q2	$2.5M	Buy	21,603 +1,055	+5%	+$121K	0.74%	62
2015 Q1	$2.37M	Buy	+20,548	New	+$2.46M	0.69%	64

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baltimore-Washington Financial Advisors's CELG Position: Q4 2016 in Review

Baltimore-Washington Financial Advisors sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 28,094 shares — an estimated $2.94M sold.

Baltimore-Washington Financial Advisors first reported a position in CELG in Q1 2015 and held it in 7 quarters. The position peaked at $2.94M in Q3 2016. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

Baltimore-Washington Financial Advisors reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
Baltimore-Washington Financial Advisors sold 28,094 Celgene Corp shares in Q4 2016, an estimated $2.94M.
Baltimore-Washington Financial Advisors first reported a position in Celgene Corp in Q1 2015 and held it in 7 quarters.
Baltimore-Washington Financial Advisors's Celgene Corp position peaked at $2.94M in Q3 2016.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2016, filed 12 Jan 2017.